Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory Research"
DOI: 10.1186/s12931-017-0688-5
Abstract: BackgroundThis study assessed the cost-effectiveness of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) in chronic obstructive pulmonary disease (COPD) patients with moderate to very severe airflow limitation and ≥1 exacerbation in the preceding year.MethodsA previously published and… read more here.
Keywords: indacaterol glycopyrronium; salmeterol fluticasone; copd; cost effective ... See more keywords
Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2021-0142
Abstract: Background: The efficacy of budesonide + formoterol therapy compared with high-dose salmeterol + fluticasone therapy plus short-acting β-agonist (SABA) has not been evaluated specifically in children. Objectives: To evaluate the efficacy and safety of budesonide + formoterol combination therapy two times a day… read more here.
Keywords: therapy; budesonide formoterol; salmeterol fluticasone;